Matches in Wikidata for { <http://www.wikidata.org/entity/Q92635899> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q92635899 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q92635899 description "scientific article published on 01 December 2019" @default.
- Q92635899 description "wetenschappelijk artikel" @default.
- Q92635899 description "наукова стаття, опублікована 1 грудня 2019" @default.
- Q92635899 name "Treatment of Menopausal Vasomotor Symptoms With Fezolinetant, a Neurokinin 3 Receptor Antagonist: A Phase 2a Trial" @default.
- Q92635899 name "Treatment of Menopausal Vasomotor Symptoms With Fezolinetant, a Neurokinin 3 Receptor Antagonist: A Phase 2a Trial" @default.
- Q92635899 type Item @default.
- Q92635899 label "Treatment of Menopausal Vasomotor Symptoms With Fezolinetant, a Neurokinin 3 Receptor Antagonist: A Phase 2a Trial" @default.
- Q92635899 label "Treatment of Menopausal Vasomotor Symptoms With Fezolinetant, a Neurokinin 3 Receptor Antagonist: A Phase 2a Trial" @default.
- Q92635899 prefLabel "Treatment of Menopausal Vasomotor Symptoms With Fezolinetant, a Neurokinin 3 Receptor Antagonist: A Phase 2a Trial" @default.
- Q92635899 prefLabel "Treatment of Menopausal Vasomotor Symptoms With Fezolinetant, a Neurokinin 3 Receptor Antagonist: A Phase 2a Trial" @default.
- Q92635899 P1433 Q92635899-FF0623C3-20F4-4B60-969D-6772C7B210C0 @default.
- Q92635899 P1476 Q92635899-8B277E7B-037D-43D2-A608-E53E062E07B3 @default.
- Q92635899 P2093 Q92635899-1815432A-533C-4866-A5B2-0E2ADB7DC674 @default.
- Q92635899 P2093 Q92635899-33CCE02F-B270-4DA0-A85E-DE83A48AF39D @default.
- Q92635899 P2093 Q92635899-3CCB1175-4B6B-4422-87FD-456E9F47DDD3 @default.
- Q92635899 P2093 Q92635899-43D850DE-BA5C-4FDE-B1A0-4BB12F4348F4 @default.
- Q92635899 P2093 Q92635899-4537F29D-2B41-4EF3-A4E5-A5C7B4F55074 @default.
- Q92635899 P2093 Q92635899-56FFBF47-01CF-4240-A448-486F18F8EAB1 @default.
- Q92635899 P2093 Q92635899-D0A30489-D066-410C-9DC3-4E4B70D8362A @default.
- Q92635899 P2093 Q92635899-E5C01206-EE22-4C70-98DD-4DA756059FC5 @default.
- Q92635899 P304 Q92635899-D47EBF70-C5DC-4577-8CFD-BB8DE3A80872 @default.
- Q92635899 P31 Q92635899-119D9E07-A7D8-4290-897B-58B268B3EC34 @default.
- Q92635899 P356 Q92635899-25007C0A-0942-453F-BBA4-04C6BD9415C1 @default.
- Q92635899 P433 Q92635899-1C47E7A3-7F13-4531-B3A6-D002A3530323 @default.
- Q92635899 P478 Q92635899-65A26B71-4DC6-4A99-9E2F-3D83B41DFFD8 @default.
- Q92635899 P577 Q92635899-BD6A8079-FA3B-4B22-AD98-75B2B0287254 @default.
- Q92635899 P698 Q92635899-AAAE16D1-8D07-47FE-8265-0441DA16966F @default.
- Q92635899 P356 JC.2019-00677 @default.
- Q92635899 P698 31415087 @default.
- Q92635899 P1433 Q3186902 @default.
- Q92635899 P1476 "Treatment of Menopausal Vasomotor Symptoms With Fezolinetant, a Neurokinin 3 Receptor Antagonist: A Phase 2a Trial" @default.
- Q92635899 P2093 "Dirk Timmerman" @default.
- Q92635899 P2093 "Gilbert Donders" @default.
- Q92635899 P2093 "Graeme L Fraser" @default.
- Q92635899 P2093 "Hamid R Hoveyda" @default.
- Q92635899 P2093 "Herman Depypere" @default.
- Q92635899 P2093 "Jean Combalbert" @default.
- Q92635899 P2093 "Peter Sieprath" @default.
- Q92635899 P2093 "Steven Ramael" @default.
- Q92635899 P304 "5893-5905" @default.
- Q92635899 P31 Q13442814 @default.
- Q92635899 P356 "10.1210/JC.2019-00677" @default.
- Q92635899 P433 "12" @default.
- Q92635899 P478 "104" @default.
- Q92635899 P577 "2019-12-01T00:00:00Z" @default.
- Q92635899 P698 "31415087" @default.